Skip to content

Remyelination in Multiple Sclerosis: a PET-MR longitudinal study investigating individual profiles of myelin repair and the contribution of neuroinflammation (SMART in MS)

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-512761-13-00
Acronym
APHP200056
Enrollment
60
Registered
2024-12-03
Start date
2022-01-24
Completion date
Unknown
Last updated
2025-04-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Remyelination in Multiple Sclerosis

Interventions

None listed

Sponsors

Assistance Publique Hopitaux De Paris
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Countries

France

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026